Here, we discuss the mechanisms of HSP70 neuroprotection in brain injury (ischemic stroke and traumatic brain injury (TBI)), along with pharmacological HSP70 inducers and their possible applications at the clinical level. This evidence concerns the gene HSPA1A and ischemic stroke.